Literature DB >> 8598065

Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats.

R Zimlichman1, D Gefel, H Eliahou, Z Matas, B Rosen, S Gass, C Ela, Y Eilam, Z Vogel, J Barg.   

Abstract

BACKGROUND: The opioidergic systems are involved in modulating nociceptive stimuli. In addition, the recent results suggest that endogenous and exogenous opioids could play a role in the modulation of blood pressure and cardiac functions. However, little is known regarding the expression and role of opioid-binding sites in the heart. The decreased sensitivity to noxious stimuli in hypertensive rats raises the possibility of different developmental pattern expression of opioid-binding sites in normotensive versus hypertensive rats. METHODS AND
RESULTS: Opioid receptor expression in hearts from hypertensive and normotensive rats was studied during heart development by binding assays. From P1 until P90, the development of the heart in the two rat strains was accompanied by a gradual increase in the density of kappa-opioid receptors. Hearts from hypertensive rats expressed significantly higher levels of kappa receptors compared with those of normotensive rats. At ages older than P7, mu-opioid receptors could not be detected in hearts of both strains, whereas delta-opioid-binding sites gradually increased until reaching adult levels. Seven-day-old cardiomyocyte cultures of both rat strains expressed similar densities of delta or kappa receptors to those observed in hearts from 7-day-old neonates. The mu-binding sites were not detected in cardiomyocytes cultures. Similar to the in vivo state, cultured myocytes from hypertensive rats had significantly higher levels of kappa-binding sites (1.5 fold) compared with those of normotensive rats. The kappa sites are pertussis toxin sensitive, and the state of coupling of the receptor to G protein is similar for the two rat strains.
CONCLUSION: The role of opioid-binding sites in the heart is not completely clear. Hypertensive rats are known to be less sensitive to noxious stimuli compared with normotensive rats. It is controversial whether the site if application of noxious stimuli plays an important role in the sensitivity to pain in hypertensive rats. We suggest that the opioidergic system could play a role in the modulation of blood pressure in addition to its known effect on nociception.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598065     DOI: 10.1161/01.cir.93.5.1020

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

1.  Eribis peptide 94 reduces infarct size in rat hearts via activation of centrally located μ opioid receptors.

Authors:  Garrett J Gross; Anna Hsu; Kasem Nithipatikom; Irina Bobrova; Erik Bissessar
Journal:  J Cardiovasc Pharmacol       Date:  2012-02       Impact factor: 3.105

Review 2.  Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart.

Authors:  John P Headrick; Louise E See Hoe; Eugene F Du Toit; Jason N Peart
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

3.  Altered regulation of natriuretic peptides in the rat heart by prenatal exposure to morphine.

Authors:  S Ernest; M Jankowski; S Mukaddam-Daher; J Cusson; J Gutkowska
Journal:  J Physiol       Date:  1998-02-01       Impact factor: 5.182

4.  Role of protein kinase C-epsilon in the development of kappa-opioid receptor tolerance to U50,488H in rat ventricular myocytes.

Authors:  Jing-Jun Zhou; Jin-Song Bian; Jian-Ming Pei; Song Wu; Hong-Yu Li; Tak-Ming Wong
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

5.  Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac kappa-opioid receptor stimulation.

Authors:  Craig Bolte; Gilbert Newman; Jo El J Schultz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

6.  Kappa and delta opioid receptor signaling is augmented in the failing heart.

Authors:  Craig Bolte; Gilbert Newman; Jo El J Schultz
Journal:  J Mol Cell Cardiol       Date:  2009-06-30       Impact factor: 5.000

7.  Cardioprotective Effects of Remifentanil in a Sympathetic Hyperactivity Model in Rabbits.

Authors:  Selen Bayındır; Necati Gökmen; Serhat Erbayraktar; Semih Küçükgüçlü; Osman Yılmaz; Ömer Şahin; Elvan Öçmen; Hale Aksu Erdost; Emel Sağıroğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-03-03

8.  Activation of peripheral opioid receptors has no effect on heart rate variability.

Authors:  Ender Ellidokuz; Dayimi Kaya; Ihsan Uslan; Ataç Celik; Ali Metin Esen; Irfan Barutça
Journal:  Clin Auton Res       Date:  2008-04-30       Impact factor: 4.435

9.  Opioid receptors and myocardial protection: do opioid agonists possess cardioprotective effects?

Authors:  K J McCormack; C B Chapleo
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 10.  Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.

Authors:  Leonid N Maslov; Igor Khaliulin; Peter R Oeltgen; Natalia V Naryzhnaya; Jian-Ming Pei; Stephen A Brown; Yury B Lishmanov; James M Downey
Journal:  Med Res Rev       Date:  2016-05-16       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.